Flexible Stenting Solutions (FSS) is a New Jersey based private company developing and commercializing flexible, strong and durable stents that are built on a proprietary FlexStent® technology platform and a unique delivery system. The Company’s broad product platform includes third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The FSS stents offer advantages over currently available stents including: greater stent flexibility, improved scaffolding and radial strength, and greater fracture and kink resistance. The company’s reconstrainable stent and delivery system offers a unique game changing technology to the peripheral stent market.

Flexible Stenting Solutions was acquired by Cordis Corporation, a division of Johnson & Johnson, on March 12, 2013.